病毒唑联合特布他林、地塞米松雾化吸入佐治急性喉气管支气管炎的疗效观察  

Clinical effect observation of Ribavirin combined Terbutaline and Dexamethasone Aerosol Inhalation for treatment of Acute Laryngotracheobronchitis (ALTB)

作　　者：周浪 

机构地区：[1]深圳市大鹏新区葵涌人民医院儿科,518119

出　　处：《中国实用医药》2013年第18期79-80,共2页China Practical Medicine

摘　　要：目的研究病毒唑、特布他林和地塞米松雾化吸入治疗对急性喉-气管-支气管炎的临床疗效。方法将经过确诊为急性喉-气管-支气管炎的病患随机分成两组,每组共70例病患。记为对照组和联合用药组。两组患者都静脉滴注"地塞米松"。此外联合用药组在此基础上给予病毒唑和特布他林以及地塞米松的雾化吸入。结果治疗三日后,联合用药组和对照组的治愈率分别为90%和71.4%;联合用药组的各种临床症状消失时间对比于对照组显著缩短。两组比较差异具有统计学意义(P<0.05)。结论联合用药组治疗急性喉-气管-支气管炎疗效好。非常值得临床推荐。Objective To study the clinical effect of ribavirin combined terbutaline and dexamethasone aerosol inhalation for treatment of acute ALTB. Methods Patients with diagnosed ALTB were randomly divided into 2 groups both with 70 cases. The control group was given dexamethasone intravenous infusion and the com-bination group was given ribavirin combined terbutaline and dexamethasone aerosol inhalation on the above ba-sis. Results After 3 days treatment,cure rates of combination group and control group were separately 90% and 71.4% ; symptom disappeared time of combination group was obviously shorter than control group （P〈0.05） . Conclusion Combination medicine for treatment of ALTB has a good clinical effect and is worth of be-ing recommended in clinical work.

关 键 词：急性喉-气管-支气管炎 病毒唑 特布他林 地塞米松 

分 类 号：R725.6[医药卫生—儿科]